Marc Oliva

15PUBLICATIONS
109CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 15, 2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.

|Jul 15, 2026
Baseline Nutritional Status and Early Treatment Response in Oropharyngeal Cancer: A Prospective Cohort Study by HPV Status (FIS 19 Study).

|Jul 14, 2026
Integration of palliative care in a multidisciplinary head and neck cancer clinic: A prospective cohort study.

|Jun 08, 2026
Phase I Trial of Intravenous VCN-01 Oncolytic Adenovirus and Durvalumab in Patients with Head and Neck Metastatic Squamous Cell Carcinoma Refractory to Immunotherapy.

|May 26, 2026
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey.

|Apr 09, 2026
Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Amaury Daste, Xiuning Le, Amani Makkouk

Pageof 3

Frequent Collaborators

4 joint publications

Lillian Siu

3 joint publications

Anna Spreafico

3 joint publications

Jesus Brenes Castro

2 joint publications

Lorena Arribas